Search Results - "BALAGON, Maria V"

Limited Susceptibility of Cynomolgus Monkeys (Macaca fascicularis) to Leprosy after Experimental Administration of Mycobacterium leprae by WALSH, Gerald P, DELA CRUZ, Eduardo C, WALSH, Douglas S, ABALOS, Rodolfo M, TAN, Esterlina V, FAJARDO, Tranquilino T, VILLAHERMOSA, Laarni G, CELLONA, Roland V, BALAGON, Maria V, WHITE, Valerie A, SAUNDERSON, Paul R

“…Cynomolgus monkeys are a useful model for human tuberculosis, but susceptibility to M. leprae is unknown. A cynomolgus model of leprosy could increase…”
Get full text

Psoriasis is characterized by altered epidermal expression of caspase 14, a novel regulator of keratinocyte terminal differentiation and barrier formation by Walsh, Douglas S., Borke, James L., Singh, Baldev B., Do, Nah-Nam, Balagon, Maria V., Abalos, Rodolfo M., Hsu, Stephen D.

Get full text

A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum by Villahermosa, Laarni G, Fajardo, Jr, Tranquilino T, Abalos, Rodolfo M, Balagon, Maria V, Tan, Esterlina V, Cellona, Roland V, Palmer, Jeffrey P, Wittes, Janet, Thomas, Steven D, Kook, Karin A, Walsh, Gerald P, Walsh, Douglas S

“…In a randomized, double-blind, double-dummy controlled study, 22 men with erythema nodosum leprosum (ENL) received six capsules containing either 100 mg (group…”
Get more information

Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients by Cellona, Roland V, Balagon, Maria F V, dela Cruz, Eduardo C, Burgos, Jasmin A, Abalos, Rodolfo M, Walsh, Gerald P, Topolski, Richard, Gelber, Robert H, Walsh, Douglas S

“…Relapse rate estimates after 2 year WHO multiple drug therapy (MDT) in multi-bacillary (MB) leprosy vary. Between 1987 and 1994, 500 MB leprosy patients…”
Get more information

Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy by Villahermosa, Laarni G, Fajardo, Jr, Tranquilino T, Abalos, Rodolfo M, Cellona, Roland V, Balagon, Maria V, Dela Cruz, Eduardo C, Tan, Esterlina V, Walsh, Gerald P, Walsh, Douglas S

“…Monthly doses of rifampin, ofloxacin, and minocycline (ROM) are expected to be effective treatment for multi-bacillary leprosy. Patients with MB leprosy…”
Get more information

Improvement in psoriasis after intradermal administration of heat-killed Mycobacterium vaccae by Balagon, Maria V., Walsh, Douglas S., Tan, Paul L., Cellona, Roland V., Abalos, Rodolfo M., Tan, Esterlina V., Fajardo Jr, Tranquilino T., Watson, James D., Walsh, Gerald P.

“…Background New treatments for psoriasis are being developed, but many are associated with limited efficacy, side‐effects, or rapid recurrence after…”
Get full text

Multiple lesions of sporotrichoid leishmaniasis in a Filipino expatriate by Walsh, Douglas S., Balagon, Maria V., Abalos, Rodolfo M., Tiongco, Estrelitta S., Cellona, Roland V., Fajardo, Tranquilino T., Walsh, Gerald P.

“…Sporotrichoid cutaneous leishmaniasis (CL) was diagnosed in a Filipino man who had worked in Saudi Arabia for 2 years. Two primary lesions—one on the forearm…”
Get full text

Detection of new leprosy cases at a walk‐in skin clinic in Cebu City, Philippines, highlights surveillance: Roberto Cortés Franco, MD, Editor by Balagon, Maria V. F., Cellona, Roland V., Fajardo, Tranquilino T., Abalos, Rodolfo M., Walsh, Douglas S., Villahermosa, Laarni G., Tan, Esterlina V., dela Cruz, Eduardo C., Walsh, Gerald P.

Get full text

Clofazimine therapy for lepromatous leprosy:a historical perspective by Fajardo, Tranquilino T., Abalos, Rodolfo M., Cruz, Eduardo C. dela, Villahermosa, Laarni G., Walsh, Douglas S., Cellona, Roland V., Balagon, Maria V., Tan, Esterlina V., Walsh, Gerald P.

Get full text

Cutaneous delayed-type hypersensitivity responsiveness in lepromatous and borderline lepromatous leprosy patients as determined by MULTITEST® CMI by WALSH, D. S, VILLAHERMOSA, L. G, BALAGON, M. V, ABALOS, R. M, FAJARDO, T. T, TAN, E. V, CELLONA, R. V, WALSH, G. P

“…To assess cell mediated immune (CMI) function in patients with lepromatous and borderline lepromatous leprosy (LL and BL), 35 patients were examined with the…”
Get full text